Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Assertio Holdings, Inc. To Acquire Spectrum Pharmaceuticals, Inc. In All Stock And CVR Transaction; Spectrum Stockholders To Receive Upfront Consideration Of 0.1783 ASRT Shares Per SPPI Share Plus One CVR For Potential Consideration Up To $1.34/Share

Author: Benzinga Newsdesk | April 25, 2023 06:06am

Posted In: ASRT SPPI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist